Efficacy and safety of semaglutide: real-world tertiary care experience from Saudi Arabia

BACKGROUND: Semaglutide, a glucagon-like peptide-1, is an effective antidiabetic drug promoting weight loss and providing cardiovascular protection. The original trials did not include participants from Saudi Arabia; hence, the study's findings are expected to be useful. OBJECTIVES: Explore the...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammad Imran Butt, Khalid Mania Alkhalifah, Muhammad Riazuddin, Saud Mohammed Almuammar, Salman Mohammed Almuammar, Ghayda Abdulkader Alhifthi, Fahad Wali Ahmed, Samia Mohamed Al Hashim, Najeeb Waheed
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2024-11-01
Series:Annals of Saudi Medicine
Online Access:http://www.annsaudimed.net/doi/10.5144/0256-4947.2024.361
Tags: Add Tag
No Tags, Be the first to tag this record!